CAH Financials

Income Statement
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025
Revenue
63.7B
+4.5%
60.9B
-7.1%
65.6B
+2.5%
64.0B
+6.4%
60.2B
Cost of Revenue
61.1B
+4.6%
58.4B
-7.6%
63.2B
+2.5%
61.7B
+6.4%
58.0B
Gross Profit
2.6B
+2.5%
2.5B
+4.2%
2.4B
+3.4%
2.3B
+5.3%
2.2B
Operating Expenses
1.8B
+1.3%
1.8B
+6.7%
1.7B
+2.5%
1.6B
-5.3%
1.7B
R&D
0
0
0
0
0
SG&A
1.6B
+5.4%
1.5B
+2.5%
1.5B
+2.9%
1.5B
-1.5%
1.5B
Operating Income
733.0M
+5.6%
694.0M
-1.8%
707.0M
+5.5%
670.0M
+45.3%
461.0M
EBITDA
1.0B
+3.4%
978.0M
+5.2%
930.0M
+0.8%
923.0M
+34.2%
688.0M
Net Income
400.0M
+5.3%
380.0M
-19.3%
471.0M
+3.7%
454.0M
+86.8%
243.0M
EPS (Basic)
$1.69
+0.0%
$1.69
-14.6%
$1.98
+4.8%
$1.89
+89.0%
$1.00
EPS (Diluted)
$1.69
+0.0%
$1.69
-14.2%
$1.97
+4.8%
$1.88
+88.0%
$1.00
Shares (Diluted)
236.0M
+0.0%
236.0M
-0.4%
237.0M
-0.8%
239.0M
+0.0%
239.0M
Cardinal Health (CAH) โ€” Financials